(Q59602388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

Jesus Maria Hernandez Rivas

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

L López-Corral

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M V Mateos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

J M Sayagués

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

E M García

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

J Bladé

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M T Hernández-García

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

P Giraldo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

J Hernández

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

8 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

2521-2529

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22565645%20AND%20SRC:MED&resulttype=core&format=json

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

A monoclonal gammopathy precedes multiple myeloma in most patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Smoldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

The Progression from MGUS to Smoldering Myeloma and Eventually to Multiple Myeloma Involves a Clonal Expansion of Genetically Abnormal Plasma Cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Deletions of CDKN2C in multiple myeloma: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Initial genome sequencing and analysis of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Development of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Fragile sites and human disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

DNA Instability at Chromosomal Fragile Sites in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Online access to CGH data of DNA sequence copy number changes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

4q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

HDAC4 protein regulates HIF1α protein lysine acetylation and cancer cell response to hypoxia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

JunD protects cells from p53-dependent senescence and apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Copy number alterations in prostate tumors and disease aggressiveness

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

The TRAIL apoptotic pathway in cancer onset, progression and therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Use of single nucleotide polymorphism-based mapping arrays to detect copy number changes and loss of heterozygosity in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Common fragile sites.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021

Common chromosomal fragile sites and cancer: focus on FRA16D.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.128

7 January 2021